CLINICAL_TRIALS trial_result · 2019-09-30

Clinical Trial Update: A Study for Participants With Metastatic Renal Cell Carcinoma [Phase 2]

Phase 2 clinical trial update for participants with metastatic renal cell carcinoma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-09-30